Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Completed
Conditions studied: Type 2 Diabetes Mellitus, Cardiovascular Diseases
In brief
This study is designed to help patients with type 2 diabetes and their clinicians: (a) identify which glucose lowering medications have the most favorable effects on heart health and other patient-important outcomes, (b) inform the timing of medication initiation, and (c) identify whether medication benefits apply equally to all adults with type 2 diabetes, or may be different based on age, sex, race/ethnicity, baseline heart health status, baseline renal function, or other factors.
Key facts
- Study ID
- NCT05073692
- Run by
- Kaiser Permanente
- People needed
- 241981
- Starts
- 2021-07-01
- Expected to finish
- 2025-03-12
- Last updated by the study team
- 2025-11-21
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Kaiser Permanente Southern California — Pasadena, California, United States
- Romain S. Neugebauer — Pleasanton, California, United States
- Kaiser Permanente Hawaii — Honolulu, Hawaii, United States
- Henry Ford Health System — Detroit, Michigan, United States
- HealthPartners Institute — Bloomington, Minnesota, United States
- Geisinger — Danville, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.